Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Tax Provisions came in at $1.2 billion in Q2 2026, up 27.15% year-over-year from $954.0 million in Q2 2025, and up 60.66% quarter-over-quarter from $755.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Tax Provisions across 18 years of filings, most recently posting $1.2 billion for Q2 2026.

  • In Q2 2026, Tax Provisions rose 27.15% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $4.2 billion (down 11.25% YoY), while the FY2025 annual figure was $5.8 billion, up 120.41% from the prior year.
  • Tax Provisions came in at $1.2 billion for Q2 2026 at Johnson & Johnson, up from $755.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.6 billion in Q1 2025 to a low of -$796.0 million in Q2 2023.
  • Average Tax Provisions over 5 years is $883.0 million, with a median of $885.0 million recorded in 2022.
  • Year-over-year, Tax Provisions slumped 211.64% in 2023 and soared 473.42% in 2025.
  • Over 5 years, Tax Provisions stood at $862.0 million in 2022, then slipped by 19.49% to $694.0 million in 2023, then plunged by 34.29% to $456.0 million in 2024, then tumbled by 132.89% to -$150.0 million in 2025, then surged by 908.67% to $1.2 billion in 2026.
  • Per Business Quant data, the three most recent Tax Provisions figures were $1.2 billion in Q2 2026, $755.0 million in Q1 2026, and -$150.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 1.21 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 662.00 Mn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -1.01 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -407.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -524.23 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 165.91 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 39.70 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 17.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 1.21 Bn
Mar 29, 2026 755.00 Mn
Dec 28, 2025 -150.00 Mn
Sep 28, 2025 2.34 Bn
Jun 29, 2025 954.00 Mn
Mar 30, 2025 2.63 Bn
Dec 29, 2024 456.00 Mn
Sep 29, 2024 644.00 Mn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 459.00 Mn
Dec 31, 2023 694.00 Mn
Oct 1, 2023 908.00 Mn
Jul 2, 2023 930.00 Mn
Apr 2, 2023 -796.00 Mn
Jan 1, 2023 1.19 Bn
Oct 2, 2022 862.00 Mn
Jul 3, 2022 1.03 Bn
Apr 3, 2022 713.00 Mn
Oct 3, 2021 182.00 Mn
Jul 4, 2021 384.00 Mn